An ameliorative protocol for the quantification of purine 5′,8-cyclo-2′-deoxynucleosides in oxidized DNA by Michael A. Terzidis & Chryssostomos Chatgilialoglu
ORIGINAL RESEARCH
published: 28 July 2015
doi: 10.3389/fchem.2015.00047
Frontiers in Chemistry | www.frontiersin.org 1 July 2015 | Volume 3 | Article 47
Edited by:
Huib Ovaa,
Netherlands Cancer Institute,
Netherlands
Reviewed by:
Mark Helm,
Johannes Gutenberg-Universität
Mainz, Germany
Rui Zhao,
Institute of Chemistry, Chinese
Academy of Sciences, China
*Correspondence:
Chryssostomos Chatgilialoglu,
Institute of Nanoscience and
Nanotechnology, National Centre of
Scientific Research “Demokritos”,
Patriarchou Grigoriou & Neapoleos
Str., 15310 Agia Paraskevi, Athens,
Greece
c.chatgilialoglu@inn.demokritos.gr;
chrys@isof.cnr.it
Specialty section:
This article was submitted to
Chemical Biology,
a section of the journal
Frontiers in Chemistry
Received: 08 March 2015
Accepted: 13 July 2015
Published: 28 July 2015
Citation:
Terzidis MA and Chatgilialoglu C
(2015) An ameliorative protocol for the
quantification of purine
5′,8-cyclo-2′-deoxynucleosides in
oxidized DNA. Front. Chem. 3:47.
doi: 10.3389/fchem.2015.00047
An ameliorative protocol for the
quantification of purine
5′,8-cyclo-2′-deoxynucleosides in
oxidized DNA
Michael A. Terzidis 1 and Chryssostomos Chatgilialoglu 1, 2*
1 Istituto per la Sintesi Organica e la Fotoreattività, Consiglio Nazionale delle Ricerche, Bologna, Italy, 2 Institute of
Nanoscience and Nanotechnology, National Centre of Scientific Research “Demokritos”, Athens, Greece
5′,8-Cyclo-2′-deoxyadenosine (cdA) and 5′,8-cyclo-2′-deoxyguanosine (cdG) are lesions
resulting from hydroxyl radical (HO·) attack on the 5′H of the nucleoside sugar moiety
and exist in both 5′R and 5′S diastereomeric forms. Increased levels of cdA and cdG
are linked to Nucleotide Excision Repair (NER) mechanism deficiency and mutagenesis.
Discrepancies in the damage measurements reported over recent years indicated the
weakness of the actual protocols, in particular for ensuring the quantitative release of
these lesions from the DNA sample and the appropriate method for their analysis. Herein
we report the detailed revision leading to a cost-effective and efficient protocol for the
DNA damage measurement, consisting of the nuclease benzonase and nuclease P1
enzymatic combination for DNA digestion followed by liquid chromatography isotope
dilution tandem mass spectrometry analysis.
Keywords: DNA damage, cyclonucleosides, enzymatic digestion protocols, isotope dilution analysis, liquid
chromatography-tandem mass spectrometry
Introduction
Hydroxyl radicals (HO·) are known for their reactivity toward DNA leading to nucleobase
modifications and strand breaks. In particular, the attack at H5′ of DNA by HO· is estimated
to occur with a 55% probability over all possible sugar positions, and produces the C5′ radical
(Aydogan et al., 2002). The chemistry of C5′ radical is very peculiar with respect to the other
positions of 2-deoxyribose in the sense that it does not generate an abasic site, but unique cyclic
base-sugar adducts are formed denominated cyclopurine lesions (Figure 1). Therefore, apart from
the usual glycosidic bond, another covalent bond between the C5′ sugar and the C8 purine carbon
atoms is present (Chatgilialoglu et al., 2011). 5′,8-Cyclo-2′-deoxyadenosine (cdA) and 5′,8-cyclo-2′-
deoxyguanosine (cdG) in their 5′R and 5′S diastereomeric forms are tandem-type lesions observed
among the DNA modifications and identified in mammalian cellular DNA in vivo (Chatgilialoglu
et al., 2011). Nowadays these lesions are considered as robust biomarkers for oxidative stress and
might be resistant to repair machinery in cells. Indeed, it has been recently found that these tandem
lesions accumulate with aging in a tissue-specific manner (liver > kidney > brain), providing
evidence that DNA repair mechanisms are inadequate to preserve the integrity of genetic material
from these lesions (Wang et al., 2011, 2012). Results from competitive transcription and adduct
bypass assay revealed that 5′S-cdG strongly inhibits transcription in vitro and in mammalian
cells, and induces transcriptional mutagenesis both in vitro and in vivo (You et al., 2012). Recent
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FIGURE 1 | 5′,8-Cyclo-2′-deoxyadenosine (cdA) and
5′,8-cyclo-2′-deoxyguanosine (cdG) lesions.
studies reported cyclopurine lesions as reliable oxidative stress
biomarkers in animal models for examination of liver injury
pathophysiology in Wilson’s disease and pigmentation (Wang
et al., 2011; Mitra et al., 2012). A direct comparison of
relative Nucleotide Excision Repair (NER) efficiencies of the
four cyclopurines has been determined in the identical sequence
contexts and in the same HeLa cell extract preparations
(Kropachev et al., 2014). The cdA and cdG lesions were
excised with similar efficiencies, but the efficiencies for both 5′R
cyclopurines were greater by a factor of ∼2 than for the 5′S
lesions. Based on molecular modeling and molecular dynamics
simulations, the structural and energetic origins of this difference
in NER efficiencies have been suggested. Indeed, the greater
stacking impairment in the 5′R stereoisomer correlates well with
its greater relative NER excision efficiency.
Modified oligonucleotides and dimers containing the
cyclopurines were synthesized and used by different research
groups for the development of enzymatic protocols aiming at the
quantitative liberation of the lesions as nucleoside units, prior to
quantification (Romieu et al., 1998, 1999; Jaruga et al., 2004). The
cocktails used in the latter studies contain the nuclease enzyme
P1, which is dependent on both zinc and water co-factors and
is known to recognize and hydrolyze single-stranded DNA and
RNA to the level of 5′-mononucleotides by concerted endo- and
exonucleolytic action (Fujimoto et al., 1975; Volbeda et al., 1991;
Romier et al., 1998). The mechanism behind the action of the
snake venom phosphodiesterase (3′-exo) and phosphodiesterase
II (5′-exo), also used in digestion mixtures, has been identified
to proceed through the formation of a nucleotidyl-enzyme
intermediate by an active-site threonine insult, on which a
double-displacement takes place (Culp et al., 1985; Cummins
and Potter, 1987). Results reported for irradiated samples of calf
thymus DNA have been critically reviewed, highlighting that
the available protocols are not the best performing test available,
and revision is needed in order to get precise damage values
and foster the potential involvement of these lesions in human
health (Chatgilialoglu et al., 2011). The objectives of this work
were to (i) develop and validate a sensitive analytical method
based on the stable isotope-dilution tandem mass spectrometry
technique using triple quadrupole mass spectrometry, and
(ii) to elucidate the hydrolytic action of several enzymes for
the satisfactory DNA digestion and quantitative release of
single nucleoside cyclopurines. We anticipate that our revised
protocol, consisting of the nuclease benzonase and nuclease P1
enzymatic combination for DNA digestion followed by liquid
chromatography isotope dilution tandem mass spectrometry
analysis, provides benefits for costs and efficiency related to DNA
damage measurement including cyclopurine lesions.
Materials and Methods
Chemicals
8-Bromo-2′-deoxyadenosine, 2′-deoxyadenosine monohydrated,
7,8-dihydro-8-oxo-2′-deoxyadenosine (8-oxo-dA), 2′-
deoxyguanosine monohydrated, 7,8-dihydro-8-oxo-2′-
deoxyguanosine 8-oxo-dG), and 8-bromo-2′-deoxyguanosine
were purchased from Berry & Associates Inc. (Dexter, USA).
[15N5]-2′-deoxyadenosine monohydrated and [15N5]-2′-
deoxyguanosine monohydrated (all >98% isotopic purity) were
purchased from Cambridge Isotope Laboratories (Andover,
USA). All the salts and solvents, thymidine, 2′-deoxycytidine,
activated calf thymus DNA, nuclease P1 from Penicillium
citrinum, phosphodiesterase II, phosphodiesterase I from
Crotalus Adamanteus venom, DNAse I, DNAse II, alkaline
phosphatase from bovine intestinal mucosa, erythro-9-(2-
hydroxy-3-nonyl)adenine hydrochoride (EHNA), benzonase
99%, deferoxamine mesylate salt, BHT and pentostatin, were
obtained from Sigma (Taufkirchen, Germany and Milan, Italy)
while the 3 kDa filters were purchased from Millipore (Bedford,
USA). Distilled and deionized water (ddH2O) was purified by a
Milli-Q system (Millipore, Bedford, USA).
Synthesis of Reference Compounds and Internal
Standards
The four diastereoisomers 5′R-cdA, 5′S-cdA, 5′R-, and 5′S-
cdG were synthesized according to published synthetic protocol
(Jimenez et al., 2004; Terzidis and Chatgilialoglu, 2013) (e.g.,
see Figure S1 for cdA). Synthesis of 15N labeled of adenine
derivatives was performed as previously reported for the
unlabeled compounds (Boussicault et al., 2008). In particular,
1mL of aqueous solution containing 1.5mM of [15N5]-dA was
prepared, flushed with N2O for 15min and γ-irradiated with
a total dose of 2 kGy at a dose rate of 4.5 Gy min−1. After
the reaction crude mixture was submitted to HPLC purification
and the peaks corresponding to [15N5]-5′R-cdA, [15N5]-5′S-cdA,
and [15N5]-8-oxo-dA were collected (Figures S2, S3). The two
diastereoisomers in ESI MS/MS analysis gave m/z 255 for the
[M+H]+ and the two diagnostic fragment ions at m/z 169 and
at m/z 141, whereas [15N5]-8-oxo-dA gave m/z 273 for the
[M + H]+ and two fragment ions at m/z 157 and m/z 130,
which correspond to the protonated 2-deoxyribose and [15N5]-
8-oxo-adenine, respectively. The synthesis of [15N5]-8-bromo-
2′-deoxyguanosine has been achieved starting from [15N5]-dG
and following a known procedure for the unlabeled compound
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(Münzel et al., 2011). In particular, 1mg (3.5µmol) of [15N5]-
dG was suspended to 500µL of acetonitrile/water mixture 4:1
in a microcentrifuge tube of 1.5mL volume. Then 1.3mg N-
bromosuccinimide (7.3µmol) was added to the suspension in
three portions and the mixture stirred at room temperature
for 2 h. After the solvent was removed under a stream of
argon, acetone (100µL) was added. The mixture was stirred at
room temperature for 4 h and then stored at −20◦C overnight.
Next, the mixture was centrifuged at 1000 g for 1min and
the supernatant was removed with a pipette. The precipitate
was washed with cold acetone (60µL), centrifuged again and
the liquid removed with a pipette. The bromo derivative was
irradiated as previously reported for the unlabeled compounds
(Chatgilialoglu et al., 2007): 1mM solution in ddH2O was
transferred into the UV irradiation apparatus, flushed with argon
for 15min, and irradiated for 30min with a UV light (5 W low
pressure Hg lamp). The reaction mixture was quenched with
a 5% NaHCO3 solution (final pH 7) and submitted to HPLC
for purification (Figure S4) affording the two diastereomers
[15N5]-5′R-cdG and [15N5]-5′S-cdG (Figures S4, S5). [15N5]-8-
oxo-dG was prepared following a literature protocol (Taghizadeh
et al., 2008). In particular, [15N5]-dG (0.24mg, 0.82µmol) was
dissolved in 164µL of water in an ultrasound bath. After, 5.45µL
of 0.5M freshly prepared ascorbic acid (2.7µmol) were added
followed by 3.3µL of 0.1M CuSO4 (3.3µmol) and 9.4µL of
30% hydrogen peroxide. The reaction mixture was stirred at
room temperature and quenched after 2 h with a 5% Na2SO3
solution. The crude was purified by HPLC (Figures S6, S7).
The two diastereoisomers in ESI MS/MS analysis gave m/z 271
for the [M + H]+ and the two diagnostic fragment ions at
m/z 185 and at m/z 206, whereas [15N5]-8-oxo-dG gave m/z
289 for the [M + H]+ and two fragment ions at m/z 173 and
m/z 145, which correspond to the protonated 2-deoxyribose and
[15N5]-8-oxo-guanine respectively. The isotopic purities of the
15N labeled compounds were found to be >99.9% by tandem
mass spectrometry analysis using an ion-trap Bruker Daltonics
MSn system. The calculations were based on the ratio between
the signals of the fragment ions corresponding to the labeled and
the natural compounds. Their UV spectra were identical to those
of the unlabeled compounds.
Determination of Purine
5′,8-Cyclo-2′-Deoxynucleosides Extinction
Coefficients
The purity of the natural standard references of purine 5′,8-
cyclo-2′-deoxynucleosides was determined after the synthesis
according to published procedures (Jimenez et al., 2004; Terzidis
and Chatgilialoglu, 2013). They were all controlled by HPLC-
UV and LC-MS2 (Agilent-Bruker Daltonics ion trap) for purity.
The purine 5′,8-cyclo-2′-deoxynucleosides obtained by the
previous procedure were desalinated using solid phase extraction
cartridges (Waters Sep-Pak R© C18-E, 120 Å, 360mg) by following
the manufacturer’s instruction. For the determination of the
extinction coefficients (ε) at the λmax of each nucleoside and, in
order to reduce pipetting errors, aqueous solutions of each were
prepared involving a five digital balance. The UV spectra were
recorded by a UV spectrophotometer.
Isotope Dilution Tandem Mass Spectrometry
Quantification
The quantification of the lesions was carried out by liquid
chromatography isotope dilution tandem mass spectrometry
technique. The calibration of the spectrometer with the natural
lesions was based on the parameters reported previously
(Belmadoui et al., 2010). The analytes were resolved on a
2mm × 150mm Luna C18 (2) 100 Å column (3µ min particle
size, Phenomenex) loaded with a pre-column C18 (2) cartridge
using an LC system (Perkin Elmer Inc., USA) coupled with
an AB Sciex 4000 triple quadrupole mass spectrometer (AB
Sciex Inc., USA) working on multiple reaction monitoring mode.
The chromatographic method used for the separation of the
analytes started with 99% of 2mM ammonium formate (solvent
A) and 1% acetonitrile (solvent B). A gradient program using
2mM ammonium formate (A) and acetonitrile (B) was involved,
0→ 20min solvent B 1 → 9.8%. The system was washed for
extra 5min with isocratic solution B 15% and additional 10min
were given for re-equilibration after each analysis. The flow rate
remained constant at 0.2mL/min, the column was thermostated
at 30◦C and the injection volume was 15µL. Linear responses
were found for injection volumes up to 30µL and upon dilution
(see Figures S8, S10, respectively, in Supplementary Material).
Preparation of the Calibration Curves
The construction of the calibration curves of the isotopic
15N5 labeled and unlabeled lesions of the four purine 5′,8-
cyclo-2′-deoxynucleosides and the two 8-oxo-7,8-dihydro-2′-
deoxynucleosides were prepared by plotting theMRM signal area
ratios of the lesions and their isotopic equivalents against their
corresponding concentration of the lesions. The concentration
of the labeled lesions were chosen carefully be close to the
concentration of the analytes in the samples (nM) and kept
constant both for the construction of the curves and the
quantification of the lesions in the samples. The latter was
based on the comparison of the MRM signal areas between
the lesions and their internal standards, and their respective
response curves (see Table S2 in Supplementary Material). For
this reason the horizontal axis values in the curves are given
as analyte concentration (Figure S9). The concentrations of
the lesions used for building up the calibration curves are
reported in Table S3. For the preparation of the different
solutions a five-digital balance was used in order to avoid
pipetting errors. The determination of concentrations of the
internal standard solutions containing the purine [15N5]-
5′,8-cyclo-2′-deoxynucleosides and [15N5]-7,8-dihydro-8-oxo-
2′-deoxyadenosine was based on their traces after HPLC-UV
analyses (at 260 nm) and the corresponding response curves
of the unlabeled equivalent compounds. The quantification of
the [15N5]-7,8-dihydro-8-oxo-2′-deoxyguanosine solution was
performed by UV spectroscopy.
HPLC-UV Analysis, Off-line Sample Cleanup and
Enrichment
HPLC-UV analysis, cleanup and enrichment of the samples were
performed on a 4.6mm × 150mm Luna C18 (2) 100 Å column
(5µ min particle size, Phenomenex) loaded with a pre-column
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C18 (2) cartridge, on an Agilent 1100 HPLC-UV system (Agilent,
USA). The gradient program used an eluent composed by 2mM
ammonium formate (solvent A), acetonitrile (solvent B), and
methanol (solvent C) (Table S5). The time windows used for the
collection of fractions containing the lesions are reported in Table
S6 (Figure S11). The collected fractions were freeze-dried, pooled,
freeze-dried again, and redissolved in 50µL ddH2O before LC-
MS/MS analysis. The quantification of the dA, dG, dC, and Thy
was based on their absorbance at 260 nm (Cui et al., 2013). The
same analytical protocol was used also for the quantification of
the normal 2′-deoxyribonucleosides in the enzymatic digestion
studies.
Lesion Stability under Acidic Conditions
The stability of the lesions against the acidic hydrolysis was also
investigated. Six aqueous mixtures of 10µL containing a mixture
of 19 pmol 8-oxo-dG, 6 pmol 5′R-cdG, 1 pmol 5′S-cdG, 5 pmol 8-
oxo-dA, 5 pmol 5′R-cdA and 3 pmol 5′S-cdA were prepared and
10µL of formic acid solutions with different concentrations were
added in order to reach 0, 0.1, 0.5, 1, 5, and 10% final formic acid
concentrations. The solutions were incubated at 37◦C for 4 h and
then quenched with cold NH4OH solution (Das et al., 2012). The
mixture of internal standard references (labeled) was added. The
samples were freeze-dried, reconstituted in 50µL of ddH2O and
analyzed by LC-MS/MS. The experiments were repeated three
times.
Enzymatic Digestion Protocols
Protocol A (Wang et al., 2011): 40µg DNA were dissolved in
10µL of Ar flushed buffer containing 0.3M AcONa pH 5.6,
10mM ZnCl2, 3mM deferoxamine mesylate, and 1mM EHNA.
Next, 4 U of Nuclease P1 (in 30mMAcONa pH 5.3, 5mM ZnCl2
and 50mM NaCl) and 5 mU phosphodiesterase II were added
and themixture was incubated in 37◦C. After 48 h, 20µL of 0.5M
Tris-HCl buffer pH 8.9 flushed with Ar were added along with
4 U of alkaline phosphatase and 5mU of phosphodiesterase I.
The mixture was incubated for extra 2 h. After quenching with
10% formic acid, the mixture was transferred in a microspin
filter (3 kDa) and centrifuged at ∼14,000 g for 20min (4◦C).
The filtrate was submitted to lyophilization (n.b., the original
protocol does not use deferoxamine, degased solutions and argon
atmosphere, but we found necessary to be added according to the
recoveries studies we performed).
Protocol B (Jaruga et al., 2004): 50µg DNA were dissolved
in 50µL of 10mM Tris-HCl buffer pH 7.5 containing 2.5µL
of 1M AcONa and 45mM ZnCl2 (final pH 6.0). Next, 5 U
of Nuclease P1 (in 30mM AcONa pH 5.3, 5mM ZnCl2 and
50mM NaCl), 4 mU phosphodiesterase I and 32 U of alkaline
phosphatase were added and the mixture was incubated at 37◦C.
After 24 h, the mixture was transferred in a microspin filter
(3 kDa) and centrifuged at ∼14,000 g for 20min (4◦C). The
filtrate was lyophilized overnight.
Protocol C (Belmadoui et al., 2010): 50µg DNA were
dissolved in 100µL of buffer containing succinic acid 20mM
pH 6, 10mM CaCl2, 3mM deferoxamine mesylate, and 1mM
EHNA. Next, 5 U of Nuclease P1 (in 30mM AcONa pH 5.3,
5mM ZnCl2 and 50mM NaCl), 4 mU phosphodiesterase II and
0.25 U DNAse II were added and the mixture was incubated
at 37◦C. After 2 h, 10µL of Tris-HCl buffer 0.5M pH 8 were
added along with 5 U of alkaline phosphatase and 3 mU of
phosphodiesterase I. The mixture was incubated for extra 2 h
at 37◦C. Finally, 10µL of buffer containing 0.2M succinic acid
pH 6, 0.1M CaCl2 together with 5 U of nuclease P1, 4 mU
phosphodiesterase II and 0.25 U DNAse II were added and the
mixture was incubated at 37◦C for 2 h before being transferred in
a microspin filter (3 kDa) and centrifuged ∼14,000 g for 20min
(4◦C). The filtrate was submitted to lyophilization.
Protocol D: 50µg DNAwere dissolved in 100µL of Ar flushed
10mMTris-HCl buffer pH 7.9 containing 10mMMgCl2, 50mM
NaCl, 0.2mM pentostatin, 5µM BHT, and 3mM deferoxamine.
Next, 3 U of benzonase (in 20mMTris HCl pH 8.0, 2mMMgCl2,
and 20mMNaCl), 4mU phosphodiesterase I, 3UDNAse I, 2mU
of PDE II and 2 U of alkaline phosphatase were added and the
mixture was incubated at 37◦C. Finally themixture was quenched
with 1% formic acid, transferred in a microspin filter (3 kDa)
and centrifuged at ∼14,000 g for 20min (4◦C). The filtrate was
submitted to lyophilization.
Protocol E: The same procedure as described in protocol
D was followed but after the first incubation, 35µL of Ar
flushed buffer containing 0.3MAcONa pH 5.6 and 10mMZnCl2
along with 0.5 U of Nuclease P1 (in 30mM AcONa pH 5.3,
5mM ZnCl2, and 50mM NaCl), 4 mU phosphodiesterase II and
125mU of DNAse II were added. The mixture was incubated
at 37◦C for extra 21 h, then 20µL of 0.5M Tris HCl pH 8.9
were added and the incubation continued for other 2 h, before
quenching and removal of the enzymes as described in the
previous protocols.
In the cases, when the samples were used for the LC-MS/MS
analysis, internal standards of all analytes were added prior to
enzymatic digestion.
Results and Discussion
Quantification of Lesions by Isotope Dilution
LC-MS/MS
Initially we have developed an HPLC-UV analytical protocol
for the satisfactory separation of the four natural 2′-
deoxyribonucleosides, the four diastereoisomers of the purine
5′,8-cyclo-2′-deoxynucleosides and the two 8-oxo- products
of dG and dA (see Figure S11 in Supplementary Material).
The quantification of the lesions was based on the liquid
chromatography isotope dilution tandem mass spectroscopy
technique. The LOD (s/n = 3) and LOQ (s/n = 10) for the
5′R-cdG, 5′S-cdG, 5′R-cdA, 5′S-cdA, 8-oxo-dG and 8-oxo-dA
were found 0.9, 0.6, 0.6, 0.2, 1.2, 0.2 fmol and 3.1, 2.2, 2.0, 0.8,
4.1 and 0.8 fmol respectively. Noteworthy, the LOD and LOQ
values found here are lower than those reported in the literature
(Wang et al., 2011, 2012) for the quantification of the lesions in
cellular DNA. A typical LC-MS/MS trace (TIC) of the six lesions
is depicted in Figure 2A together with the analytical traces of
the 5′R-cdG and isotopic labeled 5′R-cdG (Figure 2B) and the
fragmentation profiles of 5′R-cdA and 5′R-cdG (Figures 2C,D).
Regarding the stability of the lesions under acidic conditions,
it is known that the 5′S-diastereoisomers of the cdA and cdG
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FIGURE 2 | (A) Total ion current traces of the six lesions, (B) Selective ion current traces of (i) the unlabeled and (ii) isotopic labeled 5′R-cdG, (C) Diagnostic MS/MS
fragmentation profiles of the 5′R-cdA, (D) Diagnostic MS/MS fragmentation profiles of the 5′R-cdG.
are more resistant to acidic hydrolysis than the normal purine
2′-deoxyribonucleosides (dA, dG), the most resistant one being
8-oxo-dG. To our knowledge there is no information regarding
the stability of the 5′R-diastereomers under acidic hydrolysis
conditions (Das et al., 2012). In order to investigate the relative
stability of the lesions and the recovery yields under acidic
conditions, solutions containing the six lesions were added with
different percentages of formic acid and incubated at 37◦C for
4 h. The LC-MS/MS analyses showed that all the lesions are
highly resistant to acidic hydrolysis and the order of resistance
increase following the pattern: 5′S-cdG < 5′R-cdG < 5′S-
cdA < 5′R-cdA ≈ 8-oxo-dG ≈ 8-oxo-dA. The recoveries of
the lesions after 4 h incubation with formic acid are shown in
Figure 3.
The investigation of the lesion stability in the enzymatic
digestion buffers (pH = 5.6 and pH = 9) and the conditions
followed until the LC-MS/MS analysis, autosampler storage,
etc., showed that 8-oxo-dG is the only nucleoside resulting
in low recoveries when protection from oxidation (use of
metal chelators, argon, and antioxidants) is not taken into
account. The lesions stock solutions were prepared by taking
in to account their extinction coefficients, and particularly for
5′R- or 5′S-cdG found λmax = 258 nm, ε = 13850 M−1
cm−1 and for 5′R- or 5′S-cdA found λmax = 266 nm, ε =
14900 M−1 cm−1. Regarding the [15N5]-7,8-dihydro-8-oxo-2′-
deoxynucleosides were used the values reported in the literature
(Taghizadeh et al., 2008).
FIGURE 3 | Recovery of the lesions treated with different percentages
of formic acid after incubation at 37◦C for 4h. The experiments were
conducted in triplicates and errors are within the size of the symbols.
Enzymatic Digestibility Studies
One of the most important steps for the accurate quantification
of the purine 5′,8-cyclonucleosides is the enzymatic digestion for
the liberation of the lesions and the natural nucleotides to single
molecules. To our knowledge in the literature three relatively
recent enzymatic digestion protocols exist (protocols A, B, and
C), that are used to release the purine 5′,8-cyclonucleosides
from DNA. The amount of the purine 5′,8-cyclonucleosides
per million of normal nucleosides (Lesions/106 Nu) produced
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after gamma irradiation of calf thymus DNA, and the ratio
of the 5′R/5′S diastereoisomers display very different values
among the research groups working in this field (Chatgilialoglu
et al., 2011). In order to investigate the efficiency of the various
enzymatic protocols, we compared them by using the same
solution of ds-DNA that was previously split into different
aliquots. After incubation the digestion mixtures were filtered by
ultracentrifuge filter (3 kDa), the filtrates were lyophilized and
resolubilized in ddH2O before being injected into the HPLC-
UV system. From the analysis it was found that the efficiency
of the enzymatic protocols in releasing the single nucleosides
varies among protocols. Protocols A and C exhibited similar
efficiencies while protocol B reached only 50%. In our two-
steps development of the enzymatic digestion protocol we first
sough to find which protocol lead to the complete liberation
of the unmodified nucleosides. Protocols A and C were found
to give the same result (Figure S12) for the digestion of the
same DNA samples, while Protocol B reached only up to
∼50% in respect to A or C. When other protocols liberate
the same amount of unmodified nucleosides, then they can
be further considered also for their efficiency in liberation
of the other modified nucleosides (i.e., cyclonucleosides). In
fact, we evaluated the protocols A and C based on their
ability to liberate also the lesions. This evaluation showed that
Protocol A was predominant over Protocol C (Figure 5). The
new digestion protocol was designed based on the enzymatic
combination of benzonase and P1 nucleases. Benzonase was
successfully used in the quantification of 5-met-Cyt and 8-oxo-
dG (Quinlivan and Gregory, 2008; Cui et al., 2013), however
the choice of the other enzyme to couple and the exact steps
and duration of the treatment required to be determined.
The optimization of the enzymatic protocol was performed
in two phases. Initially, ds-DNA was incubated with different
amount of benzonase, DNAse I, alkaline phosphatase, and
phoshodiesterase I in 20mM Tris-HCl buffer at pH 8 containing
20mM MgCl2. It was found that the presence of 20mM NaCl
increases the reactivity of the enzymes and the HPLC-UV
analysis showed that the digestion was complete after 21 h
incubation at 37◦C with 2U of benzonase, 2U DNAse, 2U
alkaline phosphatase, and 2mU phoshodiesterase I. Figure 4
summarize the protocol steps in a flow diagram (see also Figure
S12 in Supplementary Material for the relative efficiency of the
four protocols).
Next, DNA solution (0.5mg/mL) flushed with Ar, irradiated
in a Gammacell 60Co with 60 Gy (4.1Gy/min) of irradiation
dose at ambient temperature, was split in different aliquots of
50µL each, and incubated according to the described protocol
D. For comparison, some of the ds-DNA aliquots were digested
according to Protocols A and C. Identical analytical results
were achieved for the normal nucleosides, as quantified after
the HPLC-UV analysis. On the other hand, the LC-MS/MS
quantification of the lesions in the above samples revealed that
the protocol D is much less efficient on the liberation of the
purine 5′,8-cyclo-2′-deoxynucleosides compared to protocol A,
FIGURE 4 | Flow diagram showing protocol steps.
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FIGURE 5 | Digestion efficiency of protocols A, C, and D based on the LC-MS/MS analysis. The values represent the mean of n = 3 independent
experiments. The values recorded using Protocol A was employed as 100%.
FIGURE 6 | Enzymatic protocol vs. digestibility efficiency 1 Application
of Protocol D 2 Protocol D and then second digestion with 20mU PDE
II (pH 5.6) 3 Protocol D and then second digestion with 1U nuclease P1
and 20mU PDE II (pH 5.6) 4 Protocol D and then second digestion with
1U nuclease P1 5 Protocol D, then 2nd digestion with 1U nuclease P1
(pH 5.6) and final third digestion with alkaline phosphatase and PDE I
(pH 8.9). The values recorded using Protocol A was employed as 100%.
even after increment of the enzyme units and the incubation
times (Figure 5). Considering the results for 8-oxo-dG, any of the
protocols A, C, or D gave the same value.
Stability studies of the lesions in the buffer used during
the enzymatic digestion with protocol A showed that special
precautions are necessary for keeping the recovery close to 90%
(ESCODD, 2002). Particularly, the combination of deferoxamine,
BHT, inert atmosphere, and argon-flushed buffers is used as
described elsewhere (Taghizadeh et al., 2008; Thornalley et al.,
2010). Interestingly, the control samples of the calf thymus DNA,
that were not exposed to γ-rays, were found to contain all
four cyclopurines and the two 8-oxo lesions (see Table S4 in
Supplementary Material) (Cui et al., 2013; Guerrero et al., 2013).
In order to identify the enzyme that can cleave the
phosphodiester bond in the remaining DNA fragments, after
treatment according to protocol D (Figure 6; ep1), the digestion
mixture was split to different aliquots and a buffer of 300mM
AcONa pH 5.3 containing 10mM ZnCl2 was added (until
final pH 5.8) together with 20 mU phosphodiesterase II
(Figure 6; ep2). The same procedure was followed also with a
combination of 20 mU phosphodiesterase II and 1 U nuclease
P1 (Figure 6; ep3), and by using only 1 U of nuclease P1
(Figure 6; ep4). Finally, aliquots were treated with a combination
of phosphodiesterase II, 1 U nuclease P1, DNase II according to
protocol E (Figure 6; ep5).
Studies on the analytical recoveries were conducted by
splitting a calf thymus DNA solution in multiple aliquots, spiking
half of them with the lesions before being digested according
to the enzymatic protocol E, and comparing the added amount
with calculated by the LC-MS/MS system, after subtraction of the
pre-existed in DNA amount of lesions. The calculated recoveries
for 5′R-cdG, 5′S-cdG, 5′R-cdA, 5′R-cdA, 8-oxo-dG, and 8-oxo-
dA were found 104, 95, 96, 90, 90, 113% respectively and the
coefficients of variation as 2–5%. No significant loss was recorded
during the sample workup, storage, and until the LC-MS/MS
analysis.
In this work all the published digestion protocols have been
applied to the same aliquots containing DNA irradiated with 60
Gy irradiation dose (γ-rays). Using this sampling, it was found
surprisingly that the efficiency of the digestion protocols for
the release of the single unmodified nucleosides is dissimilar in
the case of Protocol B (Figure S12 in Supplementary Material).
Additionally, when nuclease P1 was replaced by benzonase
(Protocol D) the efficiency of the lesion release could be
calculated as 30–60% (Figure 6). In order to identify the enzyme
that can catalyze the hydrolysis of remaining DNA fragments
containing the lesions, nuclease P1, and phosphodiesterase II
were used either separately or together in the first digestion
aliquots. In agreement with previous studies (Romieu et al., 1998)
the LC-MS/MS analysis revealed that only nuclease P1 is able to
lead to a complete digestion. Moreover, a subsequent activation
of alkaline phosphatase by changing pH to basic values was found
not to be necessary. The distortion that the purine 5′,8-cyclo-2′-
deoxynucleosides cause to the active sites of phoshodiesterases
can likely inhibit the formation of the necessary interactions
for the hydrolysis of nucleotidyl-enzyme intermediate by the
threonine active-site. On the contrary, the zinc-finger in the
active site of nuclease P1, activated by a water molecule, was
found to promote the hydrolysis at long incubation times.
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Noteworthly, nuclease P1 is known to hydrolyse native DNA
at much lower rate than the heat-denaturated DNA (Fujimoto
et al., 1974) and it is much more expensive than benzonase,
which is also more stable and known to hydrolyse fast both
single and double stranded DNA. The nuclease P1 buffer used,
in terms of zinc cation concentration, remained unaltered in
respect to the ones reported elsewhere (Romieu et al., 1998;
Wang et al., 2011), since our new protocol employs an off-line
HPLC clean-up that eliminates the problems related to the mass
detector deriving from the presence of non-volatile ions in the
samples. In agreement to our results, recently it has been reported
that the bulky spiroiminodihydantoin 2′-deoxynucleoside lesions
challenge the hydrolytic activity of the 3′-exo and 5′-exo
phosphodiesterases, and nuclease P1 quantitatively hydrolyzes
the phosphodiester bond between the modified (lesion) and the
normal nucleoside (Chen et al., 2013).
Conclusions
The use of purine 5′,8-cyclonucleosides as marker of DNA
damage and reporter of DNA molecular asset at the moment of
the HO· insult is increasingly appreciated in free radical research,
together with the advantage that cyclopurine markers do not
suffer the stability problems and artifactual oxidative process of
the most known 8-oxo-dG. In this paper we applied a step-
wise approach for the development, optimization and validation
of a new analytical procedure allowing the reproducible and
quantitative determination of cdA, cdG and the two 8-oxo-
lesions. Under the actual form, the procedure offers important
ameliorations to apply extensively the protocol to the affirmation
of cyclopurine biomarkers in different health conditions. The
role of the zinc finger nuclease P1 as the only suitable enzyme,
from those tested, for the quantitative liberation of the single
nucleoside lesions was assessed. Moreover, we reduced by ∼10
fold the cost of the analysis per sample with the introduction of
the nuclease benzonase.
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